CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Nektar Therapeutics Company Snapshot
Nektar Therapeutics operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nektar Therapeutics with three other companies in this sector in the United States: Medicines Company (The) (2016 sales of $167.84 million of which 100% was Development of Drugs), FibroGen Inc ($179.58 million ), and Mannkind Corporation ($174.76 million of which 100% was Therapeutic Products).

Sales Analysis. During the year ended December of 2016, sales at Nektar Therapeutics were $165.44 million. This is a sharp decrease of 28.3% versus 2015, when the company's sales were $230.78 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Nektar Therapeutics
  Stock Performance Chart for Nektar Therapeutics
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 23.20
(Figures in U.S. Dollars)
1 Week -6.5%   13 Weeks 5.2%  
4 Weeks 12.2%   52 Weeks 46.0%  
 
Nektar Therapeutics Key Data:
  Ticker: NKTR Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 165,436,000
(Year Ending Jan 2017).
Employees: 468
  Currency: U.S. Dollars Market Cap: 3,626,798,696
  Fiscal Yr Ends: December Shares Outstanding: 156,327,530
  Share Type: Common Closely Held Shares: 896,747
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.